BEAM earnings: a negative outcome, -11.4%

On November 7, 2022, Beam Therapeutics Inc. reached its earnings. The result was a negative outcome, and the stock moved -11.4% in the window around the event. It had already run -10.4% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.